+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy

Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy

Surgical Oncology 16(Suppl. 1): S83

Although several authors have demonstrated that laparoscopic total mesorectal excision (TME) is feasible, safe, and has short-term benefits over open surgery, evidence about oncological outcome is lacking. Preoperative chemoradiation has been shown to improve local control in locally advanced rectal cancer. Therefore, neoadjuvant treatment followed by laparoscopic TME has become widely used. We reviewed our series of laparoscopic TME focusing on comparison between preoperative chemoradiation therapy and primary surgery. Out of 59 patients who underwent laparoscopic TME, 20 were submitted to neoadjuvant chemoradiation and represent study population. Twenty-six patients with non-metastatic rectal cancer >T1 on pathologic TNM staging who underwent primary laparoscopic surgery were considered for comparison. No significant differences were found in operative time, in conversions to open surgery, in intra- and postoperative complications, and in anastomotic leakage rate between the two groups. No isolated local recurrence nor port-site metastases were detected in either group. Cumulative 3-year and 5-year survivals are also similar. Neoadjuvant treatment does not seem to jeopardize perioperative results of laparoscopic TME. The low incidence of local recurrence reported in both groups may be attributed to a more precise dissection allowed by the endoscopic view. Laparoscopic TME and preoperative chemoradiotherapy may significantly improve oncologic results and quality of life in patients with mid and low rectal cancer. Results should be validated by randomized trials with adequate follow-up.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054074162

Download citation: RISBibTeXText

PMID: 18042378

DOI: 10.1016/j.suronc.2007.10.033

Related references

Short-term outcomes of laparoscopic total mesorectal excision following neoadjuvant chemoradiotherapy. Surgical Endoscopy 24(4): 933-938, 2010

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients. Investigational new Drugs 27(3): 262-268, 2009

Laparoscopic-assisted mesorectal excision (LAME) after neoadjuvant chemoradiotherapy (CRT). Journal of Clinical Oncology 23(16_Suppl): 3625-3625, 2016

Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer. Annals of Surgical Oncology 23(1): 106-113, 2016

Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer. Digestive and Liver Disease 49(1): 91-97, 2017

Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy. Zhonghua Wei Chang Wai Ke Za Zhi 19(4): 436-441, 2016

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet. Oncology 11(3): 241-248, 2010

Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer. Surgical Endoscopy 25(6): 1753-1760, 2011

Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. Bmc Cancer 16: 380, 2016

Laparoscopic total mesorectal excision for rectal cancer after neoadjuvant treatment: targeting sphincter-preserving surgery. Hepato-Gastroenterology 58(110-111): 1545-1554, 2011

Laparoscopic total mesorectal excision for rectal cancer: is it the predictive factor for incomplete mesorectal excision?. Annals of Surgery 254(5): 835, 2011

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy. Plos one 10(9): E0138728, 2015

Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. Medicine 94(31): E1291, 2015

Curving h-BN thin films can create extra phonon polariton modes. Optics Letters 43(7): 1459-1462, 2018

Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: a study in 233 consecutive patients with mid or low rectal cancer. International Journal of Colorectal Disease 30(2): 197-203, 2015